why choose us

First received: January 08, 2024

Clinical Trial: Effect of Cetylpyridinium Chloride (CPC) Rinse in Viral Upper Respiratory Tract Infections (vURTI)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Viral Pharyngitis

Study Type: INTERVENTIONAL


Official Title: Randomized, Double-blind, Multicenter Pilot Clinical Trial to Evaluate the Use of a Mouthwash With Cetylpyridinium Chloride (CPC) in the Prevention and Reduction of Symptoms of Viral Upper Respiratory

Brief Summary: This is a randomized, controlled clinical trial with two parallel groups in which 150 volunteers (75 per group) will receive either VITIS CPC Protect® mouthwash (Mouthwash with cetylpyridinium chloride (CPC) as an anti-plaque antiseptic at a concentration of 0.07%) or mouthwash without cetylpyridinium chloride, as control group Subjects included in the study will be followed for 90 days.Symptoms associated with vURTIs (viral upper respiratory tract infections) should be recorded, when they appear, to determine the…

Read more